• Author: Lindsey Lu
Clear all

Survival outcomes of diffuse large B cell lymphoma beyond the rituximab era: Comprehensive analysis of a veteran population within the Veterans Health Administration over 11 years

Abstract: Introduction: The standard treatment approach for DLBCL has traditionally relied on chemo-immunotherapy with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine …